Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1Phase 1 1

Status

Completed 42Terminated 16Recruiting 4Withdrawn 3Active not recruiting 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 1Dermatologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Recurrence 1Neoplasm Metastasis 1Laryngeal Diseases 1Keratosis, Actinic 1Keratosis 1Head and Neck Neoplasms 1Colorectum 1

Interventions

Radiotherapy 91pembrolizumab 88Cyclophosphamide 84Gemcitabine 70Cisplatin 70Magnetic Resonance Spectroscopy 65Carboplatin 60Radiosurgery 55Paclitaxel 55Nivolumab 48Dexamethasone 45Bevacizumab 42Biopsy 41Fluorouracil 39durvalumab 37Surveys and Questionnaires 36Docetaxel 36fludarabine 35Doxorubicin 35Radiation 33Oxaliplatin 33Capecitabine 33Rituximab 32fludarabine phosphate 31Leucovorin 31Cytarabine 30Melphalan 29Etoposide 28Pemetrexed 27Irinotecan 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Withdrawn × OTHER × Sugars × Clear all
NCT02813902 2019-03-08

A Trial of Polypodium Leucotomos in Preventing Skin Cancer and Its Precursors

Massachusetts General Hospital

Phase 1 Withdrawn
Dermatologic

Keratosis, Skin Neoplasms, Keratosis, Actinic

NCT01427205 2013-04-05

Phase II Study of Cetuximab With or Without OSI-906 in Head and Neck Squamous Cell Carcinoma (HNSCC)

M.D. Anderson Cancer Center

Phase 2 Withdrawn
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Laryngeal Diseases, Neoplasm Metastasis, Recurrence

NCT01550900 2013-04-05

Prospective Trial of Metformin - Chemoprevention Role

M.D. Anderson Cancer Center

Phase NA Withdrawn

Colorectum

Data powered by HemOnc (CC BY 4.0) Colophon âš¡